Disclosed the monthly exercise status for September 2026 of the 2nd series of stock acquisition rights allocated to third parties. Number of shares underlying the grant: 59,000 shares; 590 rights were exercised during September, representing an exercise ratio of 3.3% of total issued rights. Unexercised rights at month-end: 2,170 rights (217,000 shares); at the end of the prior month: 2,760 rights (276,000 shares). Compliance with exercise restrictions during the period was also disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7957","jir_company_name":"Fujicopian Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7957-20261001-01.pdf","jir_short_summary":"Disclosed the monthly exercise status for September 2026 of the 2nd series of stock acquisition rights allocated to third parties. Number of shares underlying the grant: 59,000 shares; 590 rights were exercised during September, representing an exercise ratio of 3.3% of total issued rights. Unexercised rights at month-end: 2,170 rights (217,000 shares); at the end of the prior month: 2,760 rights (276,000 shares). Compliance with exercise restrictions during the period was also disclosed.","jir_summary":"### Key Points\nFujicopian Co., Ltd. published the monthly exercise status for September 2026 of the 2nd series of stock acquisition rights allocated to third parties, which were issued on March 10, 2025. Actual exercises in September totaled 590 rights; the number of shares underlying the grant is 59,000 shares, and the exercise ratio to total issued rights is 3.3%. Unexercised rights were 2,760 rights (276,000 shares) at the end of the prior month and 2,170 rights (217,000 shares) at month-end.\n\n### Exercise Status and Future Impact\nExercises during the subject month were limited to specific dates within the month (e.g., September 4, September 7, September 24, September 28, September 29, September 30), with the number of shares underlying each grant and the number of rights exercised shown for each date. The total number of listed shares as of the payment date is 1,789,487 shares. Compliance with exercise restrictions is also noted, and dilution remains limited at an exercise ratio of 3.3%. Depending on future movements of unexercised rights, an increase in the number of outstanding shares may occur.","jir_financial_highlights":"Number of shares underlying the grant: 59,000 shares (Unknown)\nExercise ratio to total issued rights: 3.3 (Unknown)\nNumber of unexercised stock acquisition rights (rights)\/(shares): 2,170 rights (217,000 shares) (Decrease from prior month-end)","jir_category":"","jir_hashtags":"#FujicopianCoLtd, #StockAcquisitionRights, #StockOptions","jir_key_figures":"Number of shares underlying the grant: 59,000 shares\nExercise ratio to total issued rights: 3.3%\nUnexercised rights at prior month-end: 2,760 rights (276,000 shares)\nUnexercised rights at month-end: 2,170 rights (217,000 shares)","jir_meta_title":"Fujicopian Co., Ltd. Announces Monthly Exercise Status of Third-Party Allocated Stock Acquisition Rights | September 2026","jir_meta_description":"Fujicopian Co., Ltd. disclosed the September 2026 monthly exercise status of the 2nd series of third-party allocated stock acquisition rights: 59,000 shares underlying the grant, 590 rights exercised, 3.3% exercise ratio, and 2,170 unexercised rights (217,000 shares).","jir_og_title":"Fujicopian Co., Ltd. Announces Monthly Exercise Status of Third-Party Allocated Stock Acquisition Rights | September 2026","jir_og_description":"September monthly exercise status disclosed by Fujicopian: 59,000 shares underlying the grant, 590 rights exercised, 2,170 unexercised rights (217,000 shares), exercise ratio 3.3%.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60969,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-126559","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n